SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-039082
Filing Date
2023-02-14
Accepted
2023-02-14 16:08:05
Documents
1
Group Members
ROBERT I. TEPPERTHIRD ROCK VENTURES GP III, L.P.THIRD ROCK VENTURES GP IV, L.P.THIRD ROCK VENTURES IV, L.P.TRV GP III, LLCTRV GP IV, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d423132dsc13ga.htm SC 13G/A 142686
  Complete submission text file 0001193125-23-039082.txt   144400
Mailing Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116
Business Address 29 NEWBURY STREET, 3RD FLOOR BOSTON MA 02116 617-585-2000
Third Rock Ventures III, L.P. (Filed by) CIK: 0001569705 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Subject) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91525 | Film No.: 23629127
SIC: 2834 Pharmaceutical Preparations